Chroma Therapeutics' Series D Round

Chroma Therapeutics raised a round of funding on June 15, 2009.

Chroma Therapeutics is a biotechnology company founded to exploit the potential of chromatin biology for cancer drug discovery. Chroma is focused on the identification of anti-cancer agents that combi…

Articles about Chroma Therapeutics' Series D Round: